Mala Kiran Talekar MD DNB, DCH
Pediatric Hematologic Oncology, Pediatric Solid Tumor Oncology
Director-Oncology Clinical Development-GlaxoSmithKline; Attending Physician, Peds Heme-Onc, Children’s Hospital of Philadelphia
Join to View Full Profile
3401 Civic Center Blvd# ChildrenPhiladelphia, PA 19104
Phone+1 215-590-3025
Fax+1 215-590-4183
Dr. Talekar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Penn State Milton S Hershey Medical CenterFellowship, Pediatric Hematology/Oncology, 2011 - 2014
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2009 - 2011
Rutgers Health/Newark Beth Israel Medical CenterInternship, Pediatrics, 2008 - 2009
Sir HN Hospital & Research CenterDNB Pediatrics, Pediatrics Residency, 2004 - 2005- Sir HN Hospital & Research CenterDCH Pediatrics, 2001 - 2003
Grant Medical CollegeClass of 2001
Certifications & Licensure
PA State Medical License 2009 - 2026
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
National Board of Examinations, IndiaDiplomate of National Board, Pediatrics
Awards, Honors, & Recognition
- NRI of the Year 2013- Student Category TimesNow, India, 2014
- Abstract Achievement Award American Society of Hematology, 2013
Publications & Presentations
PubMed
- Semi-automation of keratopathy visual acuity grading of corneal events in belantamab mafodotin clinical trials: clinical decision support software.Mala K Talekar, Jeffery L Painter, Mica A Elizalde, Michele Thomas, Heather K Stein
Frontiers in Digital Health. 2023-01-01 - 1 citationsCorrection: Discovery and clinical introduction of first-in-class imipridone ONC201.Joshua E. Allen, C. Leah B. Kline, Varun V. Prabhu, Jessica Wagner, Jo Ishizawa
Oncotarget. 2021-10-12 - 37 citationsSingle agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies.Varun V. Prabhu, Mala K. Talekar, Amriti R. Lulla, C. Leah B. Kline, Lanlan Zhou
Cell Cycle. 2018-02-19
Grant Support
- Young Investigator AwardASCO's Conquer Cancer Foundation2015–Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
